智通财经网·2025-12-28 13:19Core Viewpoint - Recently, the company announced that its subsidiary, Guangzhou Baiyunshan Biological Products Co., Ltd. (referred to as "Baiyunshan Biological"), received the drug registration certificate for the lyophilized human rabies vaccine (Vero cells) from the National Medical Products Administration, which will enhance the company's product portfolio and competitiveness in the vaccine market [1] Group 1 - The lyophilized human rabies vaccine (Vero cells) is intended for the prevention of rabies [1] - The approval of the drug registration certificate will allow Baiyunshan Biological to actively commence production of the vaccine [1] - The product will be available for sale after obtaining the biological product batch release certificate from the National Medical Products Administration [1]